Embryonics

📍 Tel Aviv, Israel🗓 Founded 2018👥 13 employees💰 Last funded Feb 2020
Embryonics is bringing novel artificial intelligence (AI) solutions to the world of IVF. Despite the market increasing steadily, success rates have disappointingly plateaued (~30%.) Taking a holistic approach, we are committed to addressing the reasons behind this with our team of expert computer engineers, medics and biologists. We design deep learning neural networks to improve embryo selection, genetic analysis and patient schematics, utilizing Big Data to service those in need. By improving and simplifying the process we hope to make IVF safer, cheaper, more accessible and above all more successful. In short, we aim to bring reproductive autonomy to parents in need, delivering them their next generation.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2018
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Israel
1
Frequently asked questions
Who invested in Embryonics?
Embryonics has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Embryonics last raise funding?
The most recent investment in Embryonics recorded on gritt.io was in February 2020.
When was Embryonics founded?
Embryonics was founded in 2018.
What industry is Embryonics in?
Embryonics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Embryonics based?
Embryonics is headquartered in Tel Aviv, Israel.